Type 3 Predictive Observational Study for Sensory Profiles in Central Sensitization in Low Back Pain Population.
CompletedNCT05097235
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
This study conducts prognostic research to develop, validate, and evaluate the predictive role of sensory profiles in the development of sensory profiles over time. Therefore, a type 3 prognostic model research will be conducted in the low back pain population.
Study details
- Official title
- Type III PROGRESS Framework for Prognosis Research: Building Prognostic Models for Sensory Profiles in the Development of Central Sensitisation in the Chronic Low Back Pain Population
- Conditions
- Sensory Profiles, Nociplastic Pain, Low Back Pain
- Sponsor
- Vrije Universiteit Brussel
- Start date
- 2022-05-01
- Primary completion
- 2023-05-31
- Sex
- All
- Age range
- from 18 Years to 60 Years
- Results posted
- No results posted in this snapshot
- Countries
- Netherlands
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * patients with acute LBP (\< six weeks) * with or without radiating pain * aged 18 to 60 years * a pain-free episode for at least 12 weeks before the onset of their current back pain. * be able to read and understand the Dutch language. Exclusion Criteria: * any specific cause of low back pain
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT05097235